Found 67 matching trials
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines PHASE3 The purpose of this observer blind study is to assess the safety in terms o...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants PHASE3 The purpose of this study is to compare the immune response, safety and rea...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately PHASE3 This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine PHASE2 This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine PHASE4 The purpose of this study is to evaluate the long-term antibody persistence...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants PHASE3 This is a follow-up of the primary series vaccination schedule in Study A3L...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age PHASE3 The purpose of this study is to evaluate and compare the immunogenicity and...
Show More Location
Seoul National University Children's Hospital
Learn More & Join Trial
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants PHASE3 The purpose of this trial is to clinically confirm that the manufacturing p...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV PHASE3 The purpose of this study is to document the immunological response to the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule PHASE3 To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Show More Location
Multiple Locations
Learn More & Join Trial